Legend Biotech Corp ADR (NASDAQ: LEGN): Analyst View Points To Future Growth
Legend Biotech Corp ADR (LEGN) concluded trading on Thursday at a closing price of $43.09, with 5.57 million shares of worth about $240.16 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.55% during that period and on October 17, 2024 the price saw […]
Now Is A Suitable Moment For A Long-Term Purchase Of Legend Biotech Corp ADR (NASDAQ: LEGN)
T. Rowe Price Associates, Inc. recently announced the acquisition of new stake in Legend Biotech Corp ADR (NASDAQ:LEGN). The institutional investor has increased its shareholding in the Healthcare company by 7.33% to 9.69 million shares with purchase of 0.66 million shares. This fresh investment now brings its stake to 5.33% valued currently at $589.43 million. […]
